0
Paradigm Biopharmaceuticals Limited Banner Image

Paradigm Biopharmaceuticals Limited

  • Ticker PAR
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Paradigm Biopharmaceuticals Limited Logo Image
  • 1-10 Employees
  • Based in Melbourne, Australia
Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable form for the treatment of bone marrow edema lesions, osteoarthritis, mucopolysaccharidosis, and alphaviral arthritis diseases. The company was incorporated in 2014 and isMore based in Melbourne, Australia.
REPORT RATINGS
4.8 / 5.0 (81)

Paradigm Biopharmaceuticals Limited reports have an aggregate usefulness score of 4.8 based on 81 reviews.

Paradigm Biopharmaceuticals Limited

Most Recent Annual Report

Paradigm Biopharmaceuticals Limited
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Paradigm Biopharmaceuticals Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!